טוען...
Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
[Image: see text] The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents. Usin...
שמור ב:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2014
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4136714/ https://ncbi.nlm.nih.gov/pubmed/25003231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm5006176 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|